|
"hsu min feng"的相關文件
顯示項目 11-17 / 17 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2007 |
Structure-Based Design and Synthesis of Highly Potent SARS-CoV 3CL Protease Inhibitors
|
Shao, Yi-Ming; Yang, Wen-Bin; Peng, Hung-Pin; Hsu, Min-Feng; Tsai, Keng-Chang; Kuo, Tun-Hsun; Wang, Andrew H.-J.; Liang, Po-Huang; Lin, Chun-Hung; Yang, An-Suei; Wong, Chi-Huey |
| 朝陽科技大學 |
2006-12-31 |
樟芝(Antrodiacamphorata)液態培養生產(1→3)-β-D-glucan多醣體之研究探討
|
徐銘豊; Hsu, Min-Feng |
| 國立臺灣大學 |
2006 |
Synthesis, Crystal Structure, Structure?Activity Relationships, and Antiviral Activity of a Potent SARS Coronavirus 3CL Protease Inhibitor
|
Yang, Syaulan; Chen, Shu-Jen; Hsu, Min-Feng; Wu, Jen-Dar; Tseng, Chien-Te K.; Liu, Yu-Fan; Chen, Hua-Chien; Kuo, Chun-Wei; Wu, Chi-Shen; Chang, Li-Wen; Chen, Wen-Chang; Liao, Shao-Ying; Chang, Teng-Yuan; Hung, Hsin-Hui; Shr, Hui-Lin; Liu, Cheng-Yuan; Huang, Yu-An; Chang, Ling-Yin; Hsu, Jen-Chi; PetersClarence J.; Wang, Andrew H.-J.; Hsu, Ming-Chu |
| 國立臺灣大學 |
2005 |
嚴重急性呼吸道症候群3CL蛋白酶之生成與以結構為基礎之藥物設計
|
許敏峯; Hsu, Min-Feng |
| 國立臺灣大學 |
2005 |
Mechanism of the Maturation Process of SARS-CoV 3CL Protease
|
Hsu, Min-Feng; Kuo, Chih-Jung; Chang, Kai-Ti; Chang, Hui-Chuan; Chou, Chia-Cheng; Ko, Tzu-Ping; Shr, Hui-Lin; Chang, Gu-Gang; Wang, Andrew H.-J.; Liang, Po-Huang |
| 臺大學術典藏 |
2005 |
嚴重急性呼吸道症候群3CL蛋白酶之生成與以結構為基礎之藥物設計
|
許敏峯; Hsu, Min-Feng; 許敏峯; Hsu, Min-Feng |
| 臺大學術典藏 |
2005 |
Mechanism of the Maturation Process of SARS-CoV 3CL Protease
|
Kuo, Chih-Jung; Chang, Kai-Ti; Chang, Hui-Chuan; Chou, Chia-Cheng; Ko, Tzu-Ping; Shr, Hui-Lin; Chang, Gu-Gang; Wang, Andrew H.-J.; Liang, Po-Huang; Hsu, Min-Feng; Hsu, Min-Feng; Kuo, Chih-Jung; Chang, Kai-Ti; Chang, Hui-Chuan; Chou, Chia-Cheng; Ko, Tzu-Ping; Shr, Hui-Lin; Chang, Gu-Gang; Wang, Andrew H.-J.; Liang, Po-Huang |
顯示項目 11-17 / 17 (共1頁)
1
每頁顯示[10|25|50]項目
|
